Sichuan Kelun Pharmaceutical Co., Ltd. (SHE: 002422)

Market Cap	49.40B
Revenue (ttm)	22.50B
Net Income (ttm)	2.96B
Shares Out	1.59B
EPS (ttm)	1.89
PE Ratio	16.45
Forward PE	16.32
Dividend	0.52 (1.70%)
Ex-Dividend Date	Oct 23, 2024

Volume	70,161,609
Open	34.28
Previous Close	33.14
Day's Range	30.07 - 34.28
52-Week Range	21.60 - 35.49
Beta	0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Sichuan Kelun Pharmaceutical

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sic...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 19,798
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2023, Sichuan Kelun Pharmaceutical's revenue was 21.45 billion, an increase of 12.69% compared to the previous year's 19.04 billion. Earnings were 2.46 billion, an increase of 44.03%.